JRC Publications Repository

JRC Publications Repository >

Browsing by Author APOSTOLIDIS Christos

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 2 to 21 of 146
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2004Advanced Aqueous Reprocessing in P&T Strategies. Process Demonstrations on Genuine Fuels and Targets.CHRISTIANSEN B.; APOSTOLIDIS Christos; COURSON O.; MALMBECK R.; CARLOS R.; PAGLIOSA Giorgio; ROEMER K.; SERRANO-PURROY D.; GLATZ Jean paulArticles in Journals
2002Age Determination of Highly Enriched Uranium. Separation and Analysis of 231Pa.MORGENSTERN A.; APOSTOLIDIS Christos; MAYER KlausArticles in Journals
2000Alpha-Emitting Bismuth Cyclohexybenzyl DTPA Constructs of Recombinant Humanized Anti-CD33 Antibodies: Pharmacokinetics, Bioactivity, Toxicity and Chemistry.NIKULA T.; MC DEVITT M.r.; WU Ch.; KOZAK R.w.; GARMESTANI K.; BRECHBIEL M.w.; CURCIO M.j.; PIPPIN C.g.; TIFFANI-JONES L.; GEERLINGS, SR. M.w., et alArticles in Journals
2005Alpha-Immunotherapy with 213Bi-Rituximab Compared to External Gamma Irradiation, Immunotherapy and Chemotherapy in B-CLL in vitro: Correlation with Clinical Chemotherapy Sensitivity.OFFNER Fritz; VANDENBULCKE Katja; DE VOS F.; JANSSENS A.; APOSTOLIDIS Christos; JANSSENS Willem; NIKULA T.k.; THIERENS H.; BRANS B.; DIERCKX R., et alArticles in Journals
2010[An(H2O)9](CF3SO3)3 (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and TheoryAPOSTOLIDIS Christos; SCHIMMELPFENNIG Bernd; MAGNANI Nicola; LINDQVIST-REIS Patric; WALTER Olaf; SYKORA Richard; MORGENSTERN Alfred; COLINEAU Eric; CACIUFFO Roberto; KLENZE R., et alArticles in Journals
2002Analysis of 237Np in Spent Fuel Solutions.MORGENSTERN A.; APOSTOLIDIS Christos; OTTMAR Herbert; MAYER KlausArticles in Journals
2011Analysis of Patient Survival in a Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic MelanomaALLEN B. J.; SINGLA A; RAJA C.; RIZVI S.; GRAHAM P.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos; MORGENSTERN AlfredArticles in Journals
2006Antibody-guided Alpha Radiation Effectively Damages Fungal BiofilmsMARTINEZ L.r.; BRYAN R.a.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; CASADEVALL A.; DADACHOVA E.Articles in Journals
2008Assessment of the Thermochemical Properties of Actinides in Molten ChloridesMASSET Patrick; APOSTOLIDIS Christos; MALMBECK Rikard; REBIZANT J.; SERP J.; GLATZ Jean-PaulArticles in Journals
2011The BaAnIV(PO4)2 (AnIV= Th; Np): a new family of layered double phosphatesWALLEZ G; BREGIROUX D.; POPA Karin; RAISON Philippe; APOSTOLIDIS Christos; LINDQVIST-REIS Patric; KONINGS Rudy; POPA AurelienArticles in Journals
2000Binding of a Bi-213 Labeled Monoclonal Antibody Targeting a Tumor Specific Mutant E-Cadherin in Different Tumor Models.ADAM C.; SCHUHMACHER C.; BECKER K.; HANDSCHUH G.; NIKULA T.; APOSTOLIDIS Christos; FISCHER K.; SCHWAIGER M.; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
1996Bis(cyclootatetraenyl)neptunium(IV).DE RIDDER Dirk; REBIZANT Jean; APOSTOLIDIS Christos; DORNBERGER ErnstArticles in Journals
2012Bismuth-213 and Actinium-225 – Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting RadioisotopesMORGENSTERN Alfred; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2008Bismuth-213 Radioimmunotherapy with C595 Anti¿MUC1 Monoclonal Antibody in an Ovarian Cancer Ascites ModelSONG E.; QU C. F.; RIZVI S.; RAJA C.; BERETOV J.; MORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; PERKINS A. D.Articles in Journals
2014Branched Amphiphilic Peptide Capsules: Cellular Uptake and Retention of Encapsulated SolutesSUKTHANKAR Pinakin; AVILA Adriana; WHITAKER Susan; IWAMOTO Takeo; MORGENSTERN Alfred; APOSTOLIDIS Christos; LIU Ke; HANZLIK Robert; DADACHOVA E.; TOMICH JohnArticles in Journals
2007Breaking Chemo- and Radioresistance with [Bi-213]anti-CD45 Antibodies in Leukemia CellsFRIESEN C.; GLATTING G.; KOOP B.; SCHWARZ K.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; DEBATIN K.m.; RESKE S.n.Articles in Journals
2001Cancer Treatment Using Bi-213 and Ac-225 in Radioimmunotherapy.APOSTOLIDIS Christos; CARLOS-MARQUEZ R.; JANSSENS Willem; MOLINET Roger; NIKULA T.; QUADI AliArticles in Journals
2013catena-Poly[[tris(acetonitrile-kN)-praseodymium(III)tris(u-trifluoromethanesulfonato-k2O:O')]APOSTOLIDIS Christos; WALTER OLAFArticles in Journals
2005Cell Death Triggered by Alpha-emitting 213Bi-immunoconjugates in HSC45-M2 Gastric Cancer Cells is different from Apoptotic Cell Death.SEIDL C.; SCHROECK H.; SEIDENSCHWANG S.; BECK R.; SCHMID E.; ABEND M.; BECKER K.-F.; APOSTOLIDIS CHRISTOS; NIKULA Tuomo; KREMMER E., et alArticles in Journals
2007Character of 5f states in the Pu-Am System from Magnetic Susceptibility, Electrical Resistivity, and Photoelectron Spectroscopy MeasurementsBACLET N.; DORMEVAL M.; HAVELA Ladislav; FOURNIER J.m.; VALOT C.; WASTIN FRANCK; GOUDER THOMAS; COLINEAU ERIC; WALKER CLIVE; BREMIER STEPHAN, et alArticles in Journals
Showing results 2 to 21 of 146

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top